Georgetown University Medical Center IRB — Washington D.C., District of Columbia

Georgetown University Medical Center IRB is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Georgetown University Medical Center IRB has participated in 1 clinical trials.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown University Medical Center IRB?

Georgetown University Medical Center IRB has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown University Medical Center IRB conducted?

Georgetown University Medical Center IRB has 1 clinical trials on record. Their work covers Carcinoma, Non-Small-Cell Lung.

Is Georgetown University Medical Center IRB accredited by Crixeo Health?

Georgetown University Medical Center IRB has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown University Medical Center IRB?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.